SlideShare a Scribd company logo
1 of 77
Genetics and epigenetics of attention-
deficit/hyperactivity disorder and comorbid
conditions
Anu Shivalikanjli
April 06, 2020
Profs. Bru Cormand and Stephen Faraone
HORIZON
2020
This project has received funding from the European Union’s Horizon 2020 research and innovation
programme under the Marie Sklodowska-Curie grant agreement No 643051.
“Mastering skills in the training network for attention deficit
hyperactivity and autism spectrum disorders”
Beneficiaries
Partners
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant
agreement No 643051.
WP 2
WP 3
WP 4
PREVALENCE AND DEFINITION
GENETICS AND EPIGENETICS
MODEL SYSTEMS
PREDICTION AND TREATMENT
WP 1
T
R
A
I
N
I
N
G
WP 5
I
M
P
A
C
T
WP 6
WP 2
WP 3
WP 4
PREVALENCE AND DEFINITION
GENETICS AND EPIGENETICS
MODEL SYSTEMS
PREDICTION AND TREATMENT
WP 1
T
R
A
I
N
I
N
G
WP 5
I
M
P
A
C
T
WP 6
WP 2 GENETICS AND EPIGENETICS
Common and rare
genetic variation
in ADHD and ASD
Epigenetics:
methylation,
miRNAs Parent-of-origin
effects in
epigenetics
Interplay
genome-
microbiome
Completed stay in UB
Setting up the data, high-
computing cluster accounts
and pipelines
Joined the lab
Bioinformatic analysis
Late 2015
JULY 2017- mid 2018
2016
2018 2019
PUblications
2020
Thesis
2021
India
Genetics and epigenetics of attention-
deficit/hyperactivity disorder and comorbid
conditions
Anu Shivalikanjli
April 06, 2020
Profs. Bru Cormand and Stephen Faraone
Background
10
1
Background
Clinical Presentation of ADHD
Three core
symptoms of
ADHD
2
Background
12 years
3
Background
Epidemiology
3.4% adults
Persistence
Neurobiology of ADHD
13
Background
Mid- Sagittal view
4
Executive
functioning
Attention
Reward
Outside left hemisphere view
Anatomical brain changes in ADHD
14
Background
5
Genetic models
15
Mendelian Model Complex Model
Variants
Disease type
Genes
Size of cohort
Whole exome/whole genome GWAS
Technology
Family Populations
6
Background
Genetic approaches
16
Background
7
General heritability
17
Heritability
due to GWS
SNPs <5%
Global
heritability
estimates of
SNPs ~20%
SNP-based heritability
>70% heritability in ADHD
Background
8
Family
burden
Comorbidities
ADHD
Core
symptoms
Clinical condition
Clinical condition Clinical condition
Comorbid disorders
e.g. Intellectual disability
Anxiety disorders
Tic disorders
ODD, CD
Comorbid disorders
e.g. Intellectual disability
Anxiety disorders
Tic disorders
Bipolar disorder
Depression
ODD, CD
Comorbid disorders
e.g. Intellectual disability
Anxiety disorders
Tic disorders
Bipolar disorder
Depression
Substance use disorder
Personality disorder
ADHD
Core
symptoms
ADHD
Core
symptoms
Adolescence
Childhood Adulthood
Background
9
Cocaine dependence
19
5.2% of adults have tried cocaine
Heritability
20% will develop addiction
Background
10
Cocaine dependence
Background
Reward Deficit
& Stress Surfeit
Executive
function deficits
Incentive
Salience
Background
11
ADHD and Cocaine dependence
No ADHD
No cocaine
dependence
ADHD ADHD + cocaine
dependence
Cognitive impulsivity
Response inhibition
Self-medication
Impulsivity
Risk-taking
ADHD
Cocaine dependence
Conduct disorder
Oppositional defiant
Drug/alcohol
exposure in
womb
[Endo-] phenotypes
(cognitive functioning, impulsivity,
dysregulations in neurotransmission)
Genetic factors
Background
12
Implicated Genes and Biomarkers
22
Probably not
useful
biomarkers
Useful biomarkers
ADHD Addiction
Background
13
Epigenetics
23
14
Background
Epigenetics
Stable changes in
gene expression
Gene function and
brain structure
15
Background
DNA Methylation
25
16
Background
MicroRNAs
17
Background
Objectives
▹ Identification of
genetic variation that
influences brain
methylation in ADHD
▹ Hypothesis-free +
hypothesis driven
▹ Identification of
common variation in
microRNA genes
that contribute to
ADHD
▹ Hypothesis-free +
hypothesis driven
▹ Genome-wide
association meta-
analysis of cocaine-
dependence: Shared
genetics with comorbid
conditions
▹ Hypothesis-free
28
1 3
2
19
Objectives
Results
 Identification of
genetic variation
that influences brain
methylation in
ADHD
 Identification of
common variation
in microRNA
genes that
contribute to
ADHD
 Genome-wide
association meta-
analysis of
cocaine-
dependence:
Shared genetics
with comorbid
conditions
30
1 3
2
20
Results
Selection of allele-specific methylation (ASM)
SNPs
31
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
21
32
Association results obtained
for ASM-variants in ADHD
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
3,896 tagSNPs
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
22
23
Functional follow-up of associated ASM-
variants/CpG
SNPs as
eQTLs for
genes
Location of CpGs
in promoter
regions
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
23
34
Functional follow-up of associated ASM-variants and
CpGs
Location of CpGs in
promoter regions
24
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
24
Functional follow-up of associated ASM-variants and
CpGs
Location of CpGs in
promoter regions
ARTN C2orf82 NEUROD6 PIDD1 RPLP2 GAL
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
25
36
Functional follow-up of associated ASM-variants and
CpGs
SNPs as eQTLs of
the same genes
ARTN C2orf82 NEUROD6 PIDD1 RPLP2 GAL
36
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
26
ARTN C2orf82 NEUROD6 PIDD1 RPLP2 GAL
37
Functional follow-up of associated ASM-variants and
CpGs
SNPs as eQTLs of
the same genes
37
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
27
cg22930187
and
cg06207804
38
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
Artemin
• Ligand of GDNF family
• survival of sensory and sympathetic peripheral neurons
• Neuron excitability
38
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
28
39
cg1304759
6
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
Same direction
C2orf82
• Proteoglycan transmembrane protein
• Highly expressed in brain tissues
39
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
29
40
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
cg2022591
5
P53-Induced
Death
Domain
Protein 1
• Cell life regulator gene
40
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
30
41
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
Correlation with
methylation levels
60 ASM SNPs
cg22930187
cg06207804
cg13047596 cg11554507 cg20225915 cg04464446
3 SNPs 45 SNPs 3 SNP 7 SNPs 2 SNPs
ARTN C2orf82 NEUROD6 PIDD1 GAL
RPLP2
Within promoter
regions of genes
eQTLs ARTN C2orf82 NEUROD6 PIDD1 GAL
RPLP2
Correlation with
brain volumes
↑ NAc ↑ CN ↓NAc ↓ CN
↓T
41
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
31
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
PGC ADHD GWAS meta-analysis is enriched in ASM-SNPs
Better OR for SNPs with low (better) p-values.
Significance
Threshold
N SNPs N ASM SNPs p-value OR
5.00E-08 303 6 1.70-03 4.92
5.00E-07 945 8 4.30E-02 2.08
5.00E-06 2,122 15 3.15E-02 1.74
5.00E-05 6,970 35 1.31E-01 1.23
5.00E-04 25,288 139 4.58E-04 1.35
5.00E-03 115,681 527 6.94E-03 1.12
5.00E-02 651,772 2790 5.54-03 1.05
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
32
43
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
Lookup
43
Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD
33
IF: 5.2
 Identification of
genetic variation
that influences brain
methylation in
ADHD
 Identification of
common variation
in microRNA
genes that
contribute to
ADHD
 Genome-wide
association meta-
analysis of
cocaine-
dependence:
Shared genetics
with comorbid
conditions
44
Results
1 3
2
34
1355
Intragenic
Clustered
Singleton
miRNAs
are <10Kb
apart
1761
autosomal
miRNA
genes
406  135
879
Exonic
Clustered
Clustered
Singleton
Intronic Host
gene
Selection of
miRNA
regions
45
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
35
Exonic
Clustered
Clustered
Singleton
1355
Intragenic
Clustered
Singleton
1761
autosomal
miRNA
genes
406  135
879
10kb
10kb 5kb
5kb
10kb
Host
gene
Intronic
10kb
Selection of regulatory
elements for miRNA
genes
miRNAs
are
<10Kb
apart
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
36
47
Association results
obtained for miRNA
common variants in
ADHD
~22K tagSNPs
19 tagSNPs
Overcoming 5% FDR
~17K tagSNPs
Retrieved p-values from summary statistics
12 Associated miRNAs
miR-6734 miR-6735 miR-6079 miR-7-1
miR-3135a miR-3666 miR-1273h
Chr 1 Chr 3 Chr 7 Chr 9 Chr 16
miR-4655 miR-6506
miR-4271 miR-5193
5’ 3’
phg
5’
5’
5’ 5’ 5’ 5’ 5’ 5’
phg
3’ 5’
Variant
location
5’: Upstream of miRNA gene
3’ Downstream of miRNA gene
phg: Promoter region of host gene
5’
miR-6872
5’
5’
5’
3’
1761 miRNAs 12 SNPs per region
47
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
37
48
Follow-up of significantly associated miRNAs
Brain
expression
12 Associated miRNAs
miR-6734 miR-6735 miR-6079 miR-7-1
miR-3135a miR-3666 miR-1273h
Chr 1 Chr 3 Chr 7 Chr 9 Chr 16
miR-4655 miR-6506
miR-4271 miR-5193 miR-6872
Validated
target genes
Network
analysis
• BrainSpan Atlas
• miRMine
• miRIAD
• Spatio-temporal miRNA
profiles in developing
human brain (Ziats and
Rennert)
• Ingenuity Pathway Analysis
• Ingenuity Pathway Analysis
o TarBase
o TargetScan Human
o miRecords
48
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
38
49
Follow-up of significantly associated miRNAs
Brain
expression
12 Associated miRNAs
miR-6734 miR-6735 miR-6079 miR-7-1
miR-3135a miR-3666 miR-1273h
Chr 1 Chr 3 Chr 7 Chr 9 Chr 16
miR-4655 miR-6506
miR-4271 miR-5193 miR-6872
Validated
target genes
Network
analysis
• BrainSpan Atlas
• miRMine
• miRIAD
• Spatio-temporal miRNA
profiles in developing
human brain (Ziats and
Rennert)
• Ingenuity Pathway Analysis
• Ingenuity Pathway Analysis
o TarBase
o TargetScan Human
o miRecords
49
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
38
50
Follow-up of significantly associated miRNAs
Brain
expression
Cerebellum
Cerebellar
cortex
Cerebellar
cortex
Primary
somato-
sensory
cortex
Primary
somato-
sensory
cortex
Ventral
parietal
cortex
12 Associated miRNAs
miR-6734 miR-6735 miR-6079 miR-7-1
miR-3135a miR-3666 miR-1273h
Chr 1 Chr 3 Chr 7 Chr 9 Chr 16
miR-4655 miR-6506
miR-4271 miR-5193 miR-6872
Primary
somato-
sensory
cortex
Primary
visual
cortex
Cerebellum
Whole brain Whole brain
Cerebellum
Whole brain
Cerebellum
Whole brain
Cerebellum
Whole brain
Cerebellum
Whole brain Whole brain
Data
unavailable
Differentially
expressed
between PFC
and
cerebellum –
late childhood
development
50
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
39
51
Follow-up of significantly associated miRNAs
Brain
expression
12 Associated miRNAs
miR-6734 miR-6735 miR-6079 miR-7-1
miR-3135a miR-3666 miR-1273h
Chr 1 Chr 3 Chr 7 Chr 9 Chr 16
miR-4655 miR-6506
miR-4271 miR-5193 miR-6872
Validated
target genes
Network
analysis
• BrainSpan Atlas
• miRMine
• miRIAD
• Spatio-temporal miRNA
profiles in developing
human brain (Ziats and
Rennert)
• Ingenuity Pathway Analysis
• Ingenuity Pathway Analysis
o TarBase
o TargetScan Human
o miRecords
51
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
39
52
18
9 1
Follow-up of significantly associated miRNAs 12 Associated miRNAs
miR-6735 miR-6079 miR-7-1
miR-3135a miR-3666 miR-1273h
Chr 1 Chr 3 Chr 7 Chr 9 Chr 16
miR-4655 miR-6506
miR-4271 miR-5193 miR-6872
Validated
target
genes
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
40
53
18
9 1
Follow-up of significantly associated miRNAs 12 Associated miRNAs
miR-7-1
miR-3666 miR-1273h
Chr 7 Chr 9 Chr 16
Validated
target
genes
41
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
41
54
Functions of validated target genes
 Lithium-responsive BIP
 Brain thalamus volumes
EGFR
SNCA
 Cognitive empathy
 Depressive episodes in BIP
EIF4E
 Parkinson disease
MKNK1  SCZ
SLC17A7
(VGLUT1)
 Brain-specific manner
 Mediates uptake of gluatamate into
synaptic vesicles
 Cognitive decline, SCZ, MDD and
bipolar disorder
TAC1
 Brain region volumes
 Intracranial volume
 Subcortical volumes
MEOX2
 Encodes neuropeptides
– neurotransmitters and
induces behavioural
response
 Risk-taking
 Feeling nervous traits
Moderate
expression in
caudate, NAc,
and putamen
miR-7-1
miR-3666
54
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
42
55
Follow-up of significantly associated miRNAs
Brain
expression
12 Associated miRNAs
miR-6734 miR-6735 miR-6079 miR-7-1
miR-3135a miR-3666 miR-1273h
Chr 1 Chr 3 Chr 7 Chr 9 Chr 16
miR-4655 miR-6506
miR-4271 miR-5193 miR-6872
Validated
target genes
Network
analysis
• BrainSpan Atlas
• miRMine
• miRIAD
• Spatio-temporal miRNA
profiles in developing
human brain (Ziats and
Rennert)
• Ingenuity Pathway Analysis
• Ingenuity Pathway Analysis
o TarBase
o TargetScan Human
o miRecords
o Using all miRNAs as
input – focal miRNAs
43
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
56
miR-
5193
IL9
miR-7-1-
3p
miR-
3135a
miR-7a-5p
miR-610
miR-6734-3p
miR-6735-3p
miR-1273h-
3p
miR-
4271
UTS2
R
GPR6
5
GPR174
ADGRA
3
ADGRE2
RGR
ADRB
2
GPR26
XCR1
ADRA2A
HTR1D
YWHAG
Adrenorecept
or
Beta arrestin
PTGER1
GPR7
8
OR10H
2
GPR161
ADGRF
4
CCKA
R
HTR4
GPR25
Network analysis
ADGRG7
C3AR1
ADGRG4
44
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
57
CCKA
R
 SCZ
YWHAG
 Moderate language laterization
 Superior frontal grey matter
volumes
 SCZ risk allele
ADGRE2  MDD
GPR26
 Encodes a protein distantly related to Serotonin
 Expressed exclusively in brain tissue
45
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
58
Follow-up of significantly associated miRNAs
Brain
expression
12 Associated miRNAs
miR-6734 miR-6735 miR-6079 miR-7-1
miR-3135a miR-3666 miR-1273h
Chr 1 Chr 3 Chr 7 Chr 9 Chr 16
miR-4655 miR-6506
miR-4271 miR-5193 miR-6872
Data
unavailable
Validated
target
genes
Orthologs
Network
analysis
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
46
59
Overlap of associated miRNA regions and GWS-ADHD loci
Demontis et
al., 2019
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
47
60
Overlap of associated miRNA regions and GWS-ADHD loci
Demontis et
al., 2019
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
48
61
Lookup
49
Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
 Identification of
genetic variation
that influences brain
methylation in
ADHD
 Identification of
common variation
in microRNA
genes that
contribute to
ADHD
 Genome-wide
association meta-
analysis of
cocaine-
dependence:
Shared genetics
with comorbid
conditions
62
Results
1 3
2
50
63
Results – Chapter 3: GWA meta-analysis of cocaine dependence
Sample sets and pipeline
N cases = 2,085
N controls=
4,293
EUR
Sample 2 Sample 3 Sample 4
468
N controls
609 504 504
N cases
1284 410 1190 1409
Illumina HumanOmni1-Quad_v1-0_B
Illumina ILMN_Human-1 Illumina HumanOmni1-Quad_v1-0_B
Illumina Human660Q-Quad_v1_A
QC PCA Imputation
SNP-based analysis
Sample 1
RICOPILI - Rapid Imputation and COmputational PIpeLIne
Gene-based analysis
METAL
MAGMA
9,290,362 markers
GWAS
51
64
Results – Chapter 3: GWA meta-analysis of cocaine dependence
Results from the GWAS meta-
analysis
QQ plot
SNP-based
analysis 23 lead SNPs = 22 genomic risk loci =
112 genes
Suggestive
Association
s
SNP to
Gene
447 - brain eQTLs - 12 genes
BTN3A2, HIST1H2AK, ZSCAN31, PRSS16,
ZNF184
Chromosom
e 6
Schizophrenia-associated
2 lead SNPs
GWAS P = 3.1e-06 and 3.4e-06
458 nominally associated SNPs
77 genes
52
65
Results – Chapter 3: GWA meta-analysis of cocaine dependence
Circo-plot of
chromosome
6 genomic
risk locus
0.8
0.6
0.
4
r2 for the
SNPs in
the GRL
<=0.2
Top SNPs in the risk locus
Chromosome ring
Chromatin interactions
eQTLs
Manhattan plot
SNPs P < 0.05
Risk locus
53
66
Results – Chapter 3: GWA meta-analysis of cocaine dependence
Gene-based
analysis
SNP-based
analysis
10% FDR
threshold
54
67
Results – Chapter 3: GWA meta-analysis of cocaine dependence
Gene-based
analysis
 Enriched in immune system and
histone-related genes
 Five SNPs nominally associated with
cocaine dependence (P < 1e-04) and
been associated with SCZ and BIP: the
risk allele is the same in all studies.
 rs17693963 - reported in five studies -
brain eQTL for: PRSS16, ZSCAN9,
ZNF184 and ZSCAN31
 Top differentially expressed genes
HIST1H2BD, HIST1H2BC, HIST1H2BH,
HIST1H2BG and HIST1H4K
- lymphoblastoid cell lines in SCZ
10% FDR threshold
55
*nominal result
2.17
23.63
68
Polygenic architecture of cocaine dependence
Results – Chapter 3: GWA meta-analysis of cocaine dependence
Partitioned heritability analysis by functional annotations on LD Score Regression (LDSC)
55
Cocaine dependence and
shared genetic factors with
comorbid conditions
(including ADHD)
Results – Chapter 3: GWA meta-analysis of cocaine dependence
56
Cocaine dependence and shared genetic factors with comorbid
conditions
Results – Chapter 3: GWA meta-analysis of cocaine dependence
Error bars: 95% confidence limits
Significance threshold: P < 7.1e-03
Genetic correlation based on LD Score (LDSC) regression
analysis
 Cocaine dependence shares genetic risk factors with several comorbid traits
-> Horizontal (biological) pleiotropy
57
Cocaine dependence and shared genetic factors with comorbid
conditions
Results – Chapter 3: GWA meta-analysis of cocaine dependence
Best fit results from Polygenic Risk Score (PRS) analysis for each tested
phenotype
Values: p-value for significance for the most predictive models
Significance threshold: P < 5.7e-04
58
72
Lookup
Results – Chapter 3: GWA meta-analysis of cocaine dependence
 The largest GWAS meta-analysis on cocaine dependence in European ancestry individuals
 Identified susceptibility regions on chromosome 6 – HIST1H2BD
IF 4.3
59
Conclusions
▹ Common genetic risk variants for ADHD
identified in a previous genome-wide
association study (GWAS) that included
20,000 cases and 35,000 controls are
enriched in SNPs that correlate with levels
of DNA methylation.
▹ Eight Allele-Specific Methylation tagSNPs
are significantly associated with ADHD and
correlate with differential methylation at
six CpG sites in cis in different brain
areas.
▹ These six CpG sites are located at
possible promoter regions of six genes
expressed in brain: ARTN, C2orf82,
NEUROD6 , PIDD1, RPLP2 and GAL.
▹ For three of these six genes, SNPs
associated with ADHD and correlating
with methylation levels are eQTLs in
brain. Consistently, methylation and
gene expression show opposite
directions: ARTN and PIDD1 (reduced
methylation, increased expression),
C2orf82 (increased methylation,
reduced expression).
▹ ADHD risk alleles are associated with
increased brain expression of ARTN
and PIDD1 and with decreased brain
expression of C2orf82.
▹ SNPs in C2orf82 correlate with
changes in brain volumes.
▹ Our study highlights the ARTN,
C2orf82 and PIDD1 genes as potential
contributors to ADHD susceptibility.
74
Conclusions – Chapter 1
60
▹ We have performed a case-control
association study to investigate the
contribution to ADHD of common genetic
variation in 1,761 autosomal miRNAs
using pre-existing GWAS data from
20,000 cases and 35,000 controls.
▹ We have identified 19 significant
associations of SNPs with ADHD that
highlight 12 miRNA genes, all located
within protein-coding genes.
▹ The associated variants are located in
the putative regulatory regions of the
miRNA genes or in the promoter region of
the host protein-coding gene.
▹ The highlighted miRNAs are
expressed in different brain tissues,
specifically in cerebellum
▹ Three of the highlighted miRNAs -
miR-3666, miR-7-1 and miR-1273h -
have validated target mRNAs.
▹ Pathway analysis of ADHD-
associated miRNAs revealed two
biological pathways. One of the
pathways involves miRNA-mediated
regulation of serotonin receptor genes
and it is likely to be involved in
neurological functions and diseases.
75
Conclusions – Chapter 2
60
▹ We have performed the largest
cocaine dependence GWAS meta-
analysis in individuals of European
ancestry, including 2,100 cases and
4,300 controls.
▹ Although the SNP-based analysis
revealed no genome-wide significant
associations with cocaine
dependence, probably due to limited
sample size, the gene-based analysis
identified the HIST1H2BD gene,
previously associated with
schizophrenia.
▹ The estimated SNP-based heritability
of cocaine dependence is
approximately 30%.
▹ A significant genetic correlation has
been observed between cocaine
dependence and ADHD,
schizophrenia, major depressive
disorder and risk-taking behaviour,
suggesting a shared genetic basis
across pathologies and traits.
▹ Polygenic risk score (PRS) analysis
shows that all the comorbid features
analysed (ADHD, schizophrenia,
major depressive disorder,
aggressiveness, antisocial personality
or risk-taking behaviour) can predict
cocaine dependence
76
Conclusions – Chapter 3
60
Genetics and epigenetics of attention-
deficit/hyperactivity disorder and comorbid
conditions
Anu Shivalikanjli
April 06, 2020
Profs. Bru Cormand and Stephen Faraone

More Related Content

Similar to Genetics and epigenetics of ADHD and comorbid conditions

Smocking can cause macular degeneration
Smocking can cause macular degenerationSmocking can cause macular degeneration
Smocking can cause macular degeneration
Mohammad Manzoor
 
Faculty Spotlight on Judy Van de Water
Faculty Spotlight on Judy Van de WaterFaculty Spotlight on Judy Van de Water
Faculty Spotlight on Judy Van de Water
Elizabeth Fox
 
Parkinson s disease gene therapy success by design meets failure by efficacy ...
Parkinson s disease gene therapy success by design meets failure by efficacy ...Parkinson s disease gene therapy success by design meets failure by efficacy ...
Parkinson s disease gene therapy success by design meets failure by efficacy ...
Elsa von Licy
 
Advancements in Neurodegenerative Disease Research
Advancements in Neurodegenerative Disease ResearchAdvancements in Neurodegenerative Disease Research
Advancements in Neurodegenerative Disease Research
ClinosolIndia
 

Similar to Genetics and epigenetics of ADHD and comorbid conditions (20)

Alzheimer's disease recent advancements
Alzheimer's disease recent advancementsAlzheimer's disease recent advancements
Alzheimer's disease recent advancements
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
Annovis Presentation - May 2021
Annovis Presentation - May 2021Annovis Presentation - May 2021
Annovis Presentation - May 2021
 
The cell &amp; evolution
The cell &amp; evolutionThe cell &amp; evolution
The cell &amp; evolution
 
Ameliorative effects of recombinant human erythropoietin ijrpp
Ameliorative effects of recombinant human erythropoietin ijrppAmeliorative effects of recombinant human erythropoietin ijrpp
Ameliorative effects of recombinant human erythropoietin ijrpp
 
multiple system atrophy-newer developments
multiple system atrophy-newer developmentsmultiple system atrophy-newer developments
multiple system atrophy-newer developments
 
SEMINARIO BIOMOL.pdf
SEMINARIO BIOMOL.pdfSEMINARIO BIOMOL.pdf
SEMINARIO BIOMOL.pdf
 
Smocking can cause macular degeneration
Smocking can cause macular degenerationSmocking can cause macular degeneration
Smocking can cause macular degeneration
 
Integrativeproject
IntegrativeprojectIntegrativeproject
Integrativeproject
 
Annovis Presentation - February 2021
Annovis Presentation - February 2021Annovis Presentation - February 2021
Annovis Presentation - February 2021
 
Faculty Spotlight on Judy Van de Water
Faculty Spotlight on Judy Van de WaterFaculty Spotlight on Judy Van de Water
Faculty Spotlight on Judy Van de Water
 
Parkinson s disease gene therapy success by design meets failure by efficacy ...
Parkinson s disease gene therapy success by design meets failure by efficacy ...Parkinson s disease gene therapy success by design meets failure by efficacy ...
Parkinson s disease gene therapy success by design meets failure by efficacy ...
 
Gene Identification in Alzheimer Disease Using Bioinformatics Analysis
Gene Identification in Alzheimer Disease Using Bioinformatics AnalysisGene Identification in Alzheimer Disease Using Bioinformatics Analysis
Gene Identification in Alzheimer Disease Using Bioinformatics Analysis
 
Neurodegenrative disorders by Dr Rbalaraman.pptx
Neurodegenrative disorders by Dr Rbalaraman.pptxNeurodegenrative disorders by Dr Rbalaraman.pptx
Neurodegenrative disorders by Dr Rbalaraman.pptx
 
Parkinson’s disease clinical research challenges and best practices 2015
Parkinson’s disease clinical research challenges and best practices 2015Parkinson’s disease clinical research challenges and best practices 2015
Parkinson’s disease clinical research challenges and best practices 2015
 
Identification of potent inhibitors against potential
Identification of potent inhibitors against potentialIdentification of potent inhibitors against potential
Identification of potent inhibitors against potential
 
Advancements in Neurodegenerative Disease Research
Advancements in Neurodegenerative Disease ResearchAdvancements in Neurodegenerative Disease Research
Advancements in Neurodegenerative Disease Research
 
ICD-10 Codes for Reporting PD – A Neurodegenerative Disorder
ICD-10 Codes for Reporting PD – A Neurodegenerative DisorderICD-10 Codes for Reporting PD – A Neurodegenerative Disorder
ICD-10 Codes for Reporting PD – A Neurodegenerative Disorder
 
ANVS (NYSE American) Annovis Presentation - October 2020
ANVS (NYSE American) Annovis Presentation - October 2020ANVS (NYSE American) Annovis Presentation - October 2020
ANVS (NYSE American) Annovis Presentation - October 2020
 
02_IJPBA_1910_21.pdf
02_IJPBA_1910_21.pdf02_IJPBA_1910_21.pdf
02_IJPBA_1910_21.pdf
 

Recently uploaded

Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Sérgio Sacani
 
Climate extremes likely to drive land mammal extinction during next supercont...
Climate extremes likely to drive land mammal extinction during next supercont...Climate extremes likely to drive land mammal extinction during next supercont...
Climate extremes likely to drive land mammal extinction during next supercont...
Sérgio Sacani
 
Isolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptxIsolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptx
GOWTHAMIM22
 
Exomoons & Exorings with the Habitable Worlds Observatory I: On the Detection...
Exomoons & Exorings with the Habitable Worlds Observatory I: On the Detection...Exomoons & Exorings with the Habitable Worlds Observatory I: On the Detection...
Exomoons & Exorings with the Habitable Worlds Observatory I: On the Detection...
Sérgio Sacani
 
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdfPests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
PirithiRaju
 
Detectability of Solar Panels as a Technosignature
Detectability of Solar Panels as a TechnosignatureDetectability of Solar Panels as a Technosignature
Detectability of Solar Panels as a Technosignature
Sérgio Sacani
 

Recently uploaded (20)

Errors: types, determination and elimination
Errors: types, determination and eliminationErrors: types, determination and elimination
Errors: types, determination and elimination
 
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
 
family therapy psychotherapy types .pdf
family therapy psychotherapy types  .pdffamily therapy psychotherapy types  .pdf
family therapy psychotherapy types .pdf
 
Climate extremes likely to drive land mammal extinction during next supercont...
Climate extremes likely to drive land mammal extinction during next supercont...Climate extremes likely to drive land mammal extinction during next supercont...
Climate extremes likely to drive land mammal extinction during next supercont...
 
RACEMIzATION AND ISOMERISATION completed.pptx
RACEMIzATION AND ISOMERISATION completed.pptxRACEMIzATION AND ISOMERISATION completed.pptx
RACEMIzATION AND ISOMERISATION completed.pptx
 
Mining Activity and Investment Opportunity in Myanmar.pptx
Mining Activity and Investment Opportunity in Myanmar.pptxMining Activity and Investment Opportunity in Myanmar.pptx
Mining Activity and Investment Opportunity in Myanmar.pptx
 
Isolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptxIsolation of AMF by wet sieving and decantation method pptx
Isolation of AMF by wet sieving and decantation method pptx
 
Plasma proteins_ Dr.Muralinath_Dr.c. kalyan
Plasma proteins_ Dr.Muralinath_Dr.c. kalyanPlasma proteins_ Dr.Muralinath_Dr.c. kalyan
Plasma proteins_ Dr.Muralinath_Dr.c. kalyan
 
NuGOweek 2024 full programme - hosted by Ghent University
NuGOweek 2024 full programme - hosted by Ghent UniversityNuGOweek 2024 full programme - hosted by Ghent University
NuGOweek 2024 full programme - hosted by Ghent University
 
Constraints on Neutrino Natal Kicks from Black-Hole Binary VFTS 243
Constraints on Neutrino Natal Kicks from Black-Hole Binary VFTS 243Constraints on Neutrino Natal Kicks from Black-Hole Binary VFTS 243
Constraints on Neutrino Natal Kicks from Black-Hole Binary VFTS 243
 
GBSN - Microbiology Lab (Microbiology Lab Safety Procedures)
GBSN -  Microbiology Lab (Microbiology Lab Safety Procedures)GBSN -  Microbiology Lab (Microbiology Lab Safety Procedures)
GBSN - Microbiology Lab (Microbiology Lab Safety Procedures)
 
NUMERICAL Proof Of TIme Electron Theory.
NUMERICAL Proof Of TIme Electron Theory.NUMERICAL Proof Of TIme Electron Theory.
NUMERICAL Proof Of TIme Electron Theory.
 
Exomoons & Exorings with the Habitable Worlds Observatory I: On the Detection...
Exomoons & Exorings with the Habitable Worlds Observatory I: On the Detection...Exomoons & Exorings with the Habitable Worlds Observatory I: On the Detection...
Exomoons & Exorings with the Habitable Worlds Observatory I: On the Detection...
 
Emergent ribozyme behaviors in oxychlorine brines indicate a unique niche for...
Emergent ribozyme behaviors in oxychlorine brines indicate a unique niche for...Emergent ribozyme behaviors in oxychlorine brines indicate a unique niche for...
Emergent ribozyme behaviors in oxychlorine brines indicate a unique niche for...
 
A Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on EarthA Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on Earth
 
WASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 Rp
WASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 RpWASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 Rp
WASP-69b’s Escaping Envelope Is Confined to a Tail Extending at Least 7 Rp
 
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdfPests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
 
Detectability of Solar Panels as a Technosignature
Detectability of Solar Panels as a TechnosignatureDetectability of Solar Panels as a Technosignature
Detectability of Solar Panels as a Technosignature
 
mixotrophy in cyanobacteria: a dual nutritional strategy
mixotrophy in cyanobacteria: a dual nutritional strategymixotrophy in cyanobacteria: a dual nutritional strategy
mixotrophy in cyanobacteria: a dual nutritional strategy
 
GBSN - Microbiology (Unit 6) Human and Microbial interaction
GBSN - Microbiology (Unit 6) Human and Microbial interactionGBSN - Microbiology (Unit 6) Human and Microbial interaction
GBSN - Microbiology (Unit 6) Human and Microbial interaction
 

Genetics and epigenetics of ADHD and comorbid conditions

  • 1. Genetics and epigenetics of attention- deficit/hyperactivity disorder and comorbid conditions Anu Shivalikanjli April 06, 2020 Profs. Bru Cormand and Stephen Faraone
  • 2. HORIZON 2020 This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 643051. “Mastering skills in the training network for attention deficit hyperactivity and autism spectrum disorders”
  • 3. Beneficiaries Partners This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 643051.
  • 4. WP 2 WP 3 WP 4 PREVALENCE AND DEFINITION GENETICS AND EPIGENETICS MODEL SYSTEMS PREDICTION AND TREATMENT WP 1 T R A I N I N G WP 5 I M P A C T WP 6
  • 5. WP 2 WP 3 WP 4 PREVALENCE AND DEFINITION GENETICS AND EPIGENETICS MODEL SYSTEMS PREDICTION AND TREATMENT WP 1 T R A I N I N G WP 5 I M P A C T WP 6
  • 6. WP 2 GENETICS AND EPIGENETICS Common and rare genetic variation in ADHD and ASD Epigenetics: methylation, miRNAs Parent-of-origin effects in epigenetics Interplay genome- microbiome
  • 7. Completed stay in UB Setting up the data, high- computing cluster accounts and pipelines Joined the lab Bioinformatic analysis Late 2015 JULY 2017- mid 2018 2016 2018 2019 PUblications 2020 Thesis 2021 India
  • 8. Genetics and epigenetics of attention- deficit/hyperactivity disorder and comorbid conditions Anu Shivalikanjli April 06, 2020 Profs. Bru Cormand and Stephen Faraone
  • 10. 10 1 Background Clinical Presentation of ADHD Three core symptoms of ADHD
  • 13. Neurobiology of ADHD 13 Background Mid- Sagittal view 4 Executive functioning Attention Reward Outside left hemisphere view
  • 14. Anatomical brain changes in ADHD 14 Background 5
  • 15. Genetic models 15 Mendelian Model Complex Model Variants Disease type Genes Size of cohort Whole exome/whole genome GWAS Technology Family Populations 6 Background
  • 17. General heritability 17 Heritability due to GWS SNPs <5% Global heritability estimates of SNPs ~20% SNP-based heritability >70% heritability in ADHD Background 8
  • 18. Family burden Comorbidities ADHD Core symptoms Clinical condition Clinical condition Clinical condition Comorbid disorders e.g. Intellectual disability Anxiety disorders Tic disorders ODD, CD Comorbid disorders e.g. Intellectual disability Anxiety disorders Tic disorders Bipolar disorder Depression ODD, CD Comorbid disorders e.g. Intellectual disability Anxiety disorders Tic disorders Bipolar disorder Depression Substance use disorder Personality disorder ADHD Core symptoms ADHD Core symptoms Adolescence Childhood Adulthood Background 9
  • 19. Cocaine dependence 19 5.2% of adults have tried cocaine Heritability 20% will develop addiction Background 10
  • 20. Cocaine dependence Background Reward Deficit & Stress Surfeit Executive function deficits Incentive Salience Background 11
  • 21. ADHD and Cocaine dependence No ADHD No cocaine dependence ADHD ADHD + cocaine dependence Cognitive impulsivity Response inhibition Self-medication Impulsivity Risk-taking ADHD Cocaine dependence Conduct disorder Oppositional defiant Drug/alcohol exposure in womb [Endo-] phenotypes (cognitive functioning, impulsivity, dysregulations in neurotransmission) Genetic factors Background 12
  • 22. Implicated Genes and Biomarkers 22 Probably not useful biomarkers Useful biomarkers ADHD Addiction Background 13
  • 24. Epigenetics Stable changes in gene expression Gene function and brain structure 15 Background
  • 28. ▹ Identification of genetic variation that influences brain methylation in ADHD ▹ Hypothesis-free + hypothesis driven ▹ Identification of common variation in microRNA genes that contribute to ADHD ▹ Hypothesis-free + hypothesis driven ▹ Genome-wide association meta- analysis of cocaine- dependence: Shared genetics with comorbid conditions ▹ Hypothesis-free 28 1 3 2 19 Objectives
  • 30.  Identification of genetic variation that influences brain methylation in ADHD  Identification of common variation in microRNA genes that contribute to ADHD  Genome-wide association meta- analysis of cocaine- dependence: Shared genetics with comorbid conditions 30 1 3 2 20 Results
  • 31. Selection of allele-specific methylation (ASM) SNPs 31 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 21
  • 32. 32 Association results obtained for ASM-variants in ADHD Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 3,896 tagSNPs Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 22
  • 33. 23 Functional follow-up of associated ASM- variants/CpG SNPs as eQTLs for genes Location of CpGs in promoter regions Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 23
  • 34. 34 Functional follow-up of associated ASM-variants and CpGs Location of CpGs in promoter regions 24 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 24
  • 35. Functional follow-up of associated ASM-variants and CpGs Location of CpGs in promoter regions ARTN C2orf82 NEUROD6 PIDD1 RPLP2 GAL Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 25
  • 36. 36 Functional follow-up of associated ASM-variants and CpGs SNPs as eQTLs of the same genes ARTN C2orf82 NEUROD6 PIDD1 RPLP2 GAL 36 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 26
  • 37. ARTN C2orf82 NEUROD6 PIDD1 RPLP2 GAL 37 Functional follow-up of associated ASM-variants and CpGs SNPs as eQTLs of the same genes 37 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 27
  • 38. cg22930187 and cg06207804 38 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD Artemin • Ligand of GDNF family • survival of sensory and sympathetic peripheral neurons • Neuron excitability 38 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 28
  • 39. 39 cg1304759 6 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD Same direction C2orf82 • Proteoglycan transmembrane protein • Highly expressed in brain tissues 39 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 29
  • 40. 40 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD cg2022591 5 P53-Induced Death Domain Protein 1 • Cell life regulator gene 40 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 30
  • 41. 41 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD Correlation with methylation levels 60 ASM SNPs cg22930187 cg06207804 cg13047596 cg11554507 cg20225915 cg04464446 3 SNPs 45 SNPs 3 SNP 7 SNPs 2 SNPs ARTN C2orf82 NEUROD6 PIDD1 GAL RPLP2 Within promoter regions of genes eQTLs ARTN C2orf82 NEUROD6 PIDD1 GAL RPLP2 Correlation with brain volumes ↑ NAc ↑ CN ↓NAc ↓ CN ↓T 41 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 31
  • 42. Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD PGC ADHD GWAS meta-analysis is enriched in ASM-SNPs Better OR for SNPs with low (better) p-values. Significance Threshold N SNPs N ASM SNPs p-value OR 5.00E-08 303 6 1.70-03 4.92 5.00E-07 945 8 4.30E-02 2.08 5.00E-06 2,122 15 3.15E-02 1.74 5.00E-05 6,970 35 1.31E-01 1.23 5.00E-04 25,288 139 4.58E-04 1.35 5.00E-03 115,681 527 6.94E-03 1.12 5.00E-02 651,772 2790 5.54-03 1.05 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 32
  • 43. 43 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD Lookup 43 Results – Chapter 1: Identification of genetic variation that influences brain methylation in ADHD 33 IF: 5.2
  • 44.  Identification of genetic variation that influences brain methylation in ADHD  Identification of common variation in microRNA genes that contribute to ADHD  Genome-wide association meta- analysis of cocaine- dependence: Shared genetics with comorbid conditions 44 Results 1 3 2 34
  • 45. 1355 Intragenic Clustered Singleton miRNAs are <10Kb apart 1761 autosomal miRNA genes 406  135 879 Exonic Clustered Clustered Singleton Intronic Host gene Selection of miRNA regions 45 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 35
  • 46. Exonic Clustered Clustered Singleton 1355 Intragenic Clustered Singleton 1761 autosomal miRNA genes 406  135 879 10kb 10kb 5kb 5kb 10kb Host gene Intronic 10kb Selection of regulatory elements for miRNA genes miRNAs are <10Kb apart Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 36
  • 47. 47 Association results obtained for miRNA common variants in ADHD ~22K tagSNPs 19 tagSNPs Overcoming 5% FDR ~17K tagSNPs Retrieved p-values from summary statistics 12 Associated miRNAs miR-6734 miR-6735 miR-6079 miR-7-1 miR-3135a miR-3666 miR-1273h Chr 1 Chr 3 Chr 7 Chr 9 Chr 16 miR-4655 miR-6506 miR-4271 miR-5193 5’ 3’ phg 5’ 5’ 5’ 5’ 5’ 5’ 5’ 5’ phg 3’ 5’ Variant location 5’: Upstream of miRNA gene 3’ Downstream of miRNA gene phg: Promoter region of host gene 5’ miR-6872 5’ 5’ 5’ 3’ 1761 miRNAs 12 SNPs per region 47 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 37
  • 48. 48 Follow-up of significantly associated miRNAs Brain expression 12 Associated miRNAs miR-6734 miR-6735 miR-6079 miR-7-1 miR-3135a miR-3666 miR-1273h Chr 1 Chr 3 Chr 7 Chr 9 Chr 16 miR-4655 miR-6506 miR-4271 miR-5193 miR-6872 Validated target genes Network analysis • BrainSpan Atlas • miRMine • miRIAD • Spatio-temporal miRNA profiles in developing human brain (Ziats and Rennert) • Ingenuity Pathway Analysis • Ingenuity Pathway Analysis o TarBase o TargetScan Human o miRecords 48 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 38
  • 49. 49 Follow-up of significantly associated miRNAs Brain expression 12 Associated miRNAs miR-6734 miR-6735 miR-6079 miR-7-1 miR-3135a miR-3666 miR-1273h Chr 1 Chr 3 Chr 7 Chr 9 Chr 16 miR-4655 miR-6506 miR-4271 miR-5193 miR-6872 Validated target genes Network analysis • BrainSpan Atlas • miRMine • miRIAD • Spatio-temporal miRNA profiles in developing human brain (Ziats and Rennert) • Ingenuity Pathway Analysis • Ingenuity Pathway Analysis o TarBase o TargetScan Human o miRecords 49 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 38
  • 50. 50 Follow-up of significantly associated miRNAs Brain expression Cerebellum Cerebellar cortex Cerebellar cortex Primary somato- sensory cortex Primary somato- sensory cortex Ventral parietal cortex 12 Associated miRNAs miR-6734 miR-6735 miR-6079 miR-7-1 miR-3135a miR-3666 miR-1273h Chr 1 Chr 3 Chr 7 Chr 9 Chr 16 miR-4655 miR-6506 miR-4271 miR-5193 miR-6872 Primary somato- sensory cortex Primary visual cortex Cerebellum Whole brain Whole brain Cerebellum Whole brain Cerebellum Whole brain Cerebellum Whole brain Cerebellum Whole brain Whole brain Data unavailable Differentially expressed between PFC and cerebellum – late childhood development 50 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 39
  • 51. 51 Follow-up of significantly associated miRNAs Brain expression 12 Associated miRNAs miR-6734 miR-6735 miR-6079 miR-7-1 miR-3135a miR-3666 miR-1273h Chr 1 Chr 3 Chr 7 Chr 9 Chr 16 miR-4655 miR-6506 miR-4271 miR-5193 miR-6872 Validated target genes Network analysis • BrainSpan Atlas • miRMine • miRIAD • Spatio-temporal miRNA profiles in developing human brain (Ziats and Rennert) • Ingenuity Pathway Analysis • Ingenuity Pathway Analysis o TarBase o TargetScan Human o miRecords 51 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 39
  • 52. 52 18 9 1 Follow-up of significantly associated miRNAs 12 Associated miRNAs miR-6735 miR-6079 miR-7-1 miR-3135a miR-3666 miR-1273h Chr 1 Chr 3 Chr 7 Chr 9 Chr 16 miR-4655 miR-6506 miR-4271 miR-5193 miR-6872 Validated target genes Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 40
  • 53. 53 18 9 1 Follow-up of significantly associated miRNAs 12 Associated miRNAs miR-7-1 miR-3666 miR-1273h Chr 7 Chr 9 Chr 16 Validated target genes 41 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 41
  • 54. 54 Functions of validated target genes  Lithium-responsive BIP  Brain thalamus volumes EGFR SNCA  Cognitive empathy  Depressive episodes in BIP EIF4E  Parkinson disease MKNK1  SCZ SLC17A7 (VGLUT1)  Brain-specific manner  Mediates uptake of gluatamate into synaptic vesicles  Cognitive decline, SCZ, MDD and bipolar disorder TAC1  Brain region volumes  Intracranial volume  Subcortical volumes MEOX2  Encodes neuropeptides – neurotransmitters and induces behavioural response  Risk-taking  Feeling nervous traits Moderate expression in caudate, NAc, and putamen miR-7-1 miR-3666 54 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 42
  • 55. 55 Follow-up of significantly associated miRNAs Brain expression 12 Associated miRNAs miR-6734 miR-6735 miR-6079 miR-7-1 miR-3135a miR-3666 miR-1273h Chr 1 Chr 3 Chr 7 Chr 9 Chr 16 miR-4655 miR-6506 miR-4271 miR-5193 miR-6872 Validated target genes Network analysis • BrainSpan Atlas • miRMine • miRIAD • Spatio-temporal miRNA profiles in developing human brain (Ziats and Rennert) • Ingenuity Pathway Analysis • Ingenuity Pathway Analysis o TarBase o TargetScan Human o miRecords o Using all miRNAs as input – focal miRNAs 43 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
  • 57. 57 CCKA R  SCZ YWHAG  Moderate language laterization  Superior frontal grey matter volumes  SCZ risk allele ADGRE2  MDD GPR26  Encodes a protein distantly related to Serotonin  Expressed exclusively in brain tissue 45 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
  • 58. 58 Follow-up of significantly associated miRNAs Brain expression 12 Associated miRNAs miR-6734 miR-6735 miR-6079 miR-7-1 miR-3135a miR-3666 miR-1273h Chr 1 Chr 3 Chr 7 Chr 9 Chr 16 miR-4655 miR-6506 miR-4271 miR-5193 miR-6872 Data unavailable Validated target genes Orthologs Network analysis Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 46
  • 59. 59 Overlap of associated miRNA regions and GWS-ADHD loci Demontis et al., 2019 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 47
  • 60. 60 Overlap of associated miRNA regions and GWS-ADHD loci Demontis et al., 2019 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD 48
  • 61. 61 Lookup 49 Results - Chapter 2: Role of common variation in micro-RNA genes in ADHD
  • 62.  Identification of genetic variation that influences brain methylation in ADHD  Identification of common variation in microRNA genes that contribute to ADHD  Genome-wide association meta- analysis of cocaine- dependence: Shared genetics with comorbid conditions 62 Results 1 3 2 50
  • 63. 63 Results – Chapter 3: GWA meta-analysis of cocaine dependence Sample sets and pipeline N cases = 2,085 N controls= 4,293 EUR Sample 2 Sample 3 Sample 4 468 N controls 609 504 504 N cases 1284 410 1190 1409 Illumina HumanOmni1-Quad_v1-0_B Illumina ILMN_Human-1 Illumina HumanOmni1-Quad_v1-0_B Illumina Human660Q-Quad_v1_A QC PCA Imputation SNP-based analysis Sample 1 RICOPILI - Rapid Imputation and COmputational PIpeLIne Gene-based analysis METAL MAGMA 9,290,362 markers GWAS 51
  • 64. 64 Results – Chapter 3: GWA meta-analysis of cocaine dependence Results from the GWAS meta- analysis QQ plot SNP-based analysis 23 lead SNPs = 22 genomic risk loci = 112 genes Suggestive Association s SNP to Gene 447 - brain eQTLs - 12 genes BTN3A2, HIST1H2AK, ZSCAN31, PRSS16, ZNF184 Chromosom e 6 Schizophrenia-associated 2 lead SNPs GWAS P = 3.1e-06 and 3.4e-06 458 nominally associated SNPs 77 genes 52
  • 65. 65 Results – Chapter 3: GWA meta-analysis of cocaine dependence Circo-plot of chromosome 6 genomic risk locus 0.8 0.6 0. 4 r2 for the SNPs in the GRL <=0.2 Top SNPs in the risk locus Chromosome ring Chromatin interactions eQTLs Manhattan plot SNPs P < 0.05 Risk locus 53
  • 66. 66 Results – Chapter 3: GWA meta-analysis of cocaine dependence Gene-based analysis SNP-based analysis 10% FDR threshold 54
  • 67. 67 Results – Chapter 3: GWA meta-analysis of cocaine dependence Gene-based analysis  Enriched in immune system and histone-related genes  Five SNPs nominally associated with cocaine dependence (P < 1e-04) and been associated with SCZ and BIP: the risk allele is the same in all studies.  rs17693963 - reported in five studies - brain eQTL for: PRSS16, ZSCAN9, ZNF184 and ZSCAN31  Top differentially expressed genes HIST1H2BD, HIST1H2BC, HIST1H2BH, HIST1H2BG and HIST1H4K - lymphoblastoid cell lines in SCZ 10% FDR threshold 55
  • 68. *nominal result 2.17 23.63 68 Polygenic architecture of cocaine dependence Results – Chapter 3: GWA meta-analysis of cocaine dependence Partitioned heritability analysis by functional annotations on LD Score Regression (LDSC) 55
  • 69. Cocaine dependence and shared genetic factors with comorbid conditions (including ADHD) Results – Chapter 3: GWA meta-analysis of cocaine dependence 56
  • 70. Cocaine dependence and shared genetic factors with comorbid conditions Results – Chapter 3: GWA meta-analysis of cocaine dependence Error bars: 95% confidence limits Significance threshold: P < 7.1e-03 Genetic correlation based on LD Score (LDSC) regression analysis  Cocaine dependence shares genetic risk factors with several comorbid traits -> Horizontal (biological) pleiotropy 57
  • 71. Cocaine dependence and shared genetic factors with comorbid conditions Results – Chapter 3: GWA meta-analysis of cocaine dependence Best fit results from Polygenic Risk Score (PRS) analysis for each tested phenotype Values: p-value for significance for the most predictive models Significance threshold: P < 5.7e-04 58
  • 72. 72 Lookup Results – Chapter 3: GWA meta-analysis of cocaine dependence  The largest GWAS meta-analysis on cocaine dependence in European ancestry individuals  Identified susceptibility regions on chromosome 6 – HIST1H2BD IF 4.3 59
  • 74. ▹ Common genetic risk variants for ADHD identified in a previous genome-wide association study (GWAS) that included 20,000 cases and 35,000 controls are enriched in SNPs that correlate with levels of DNA methylation. ▹ Eight Allele-Specific Methylation tagSNPs are significantly associated with ADHD and correlate with differential methylation at six CpG sites in cis in different brain areas. ▹ These six CpG sites are located at possible promoter regions of six genes expressed in brain: ARTN, C2orf82, NEUROD6 , PIDD1, RPLP2 and GAL. ▹ For three of these six genes, SNPs associated with ADHD and correlating with methylation levels are eQTLs in brain. Consistently, methylation and gene expression show opposite directions: ARTN and PIDD1 (reduced methylation, increased expression), C2orf82 (increased methylation, reduced expression). ▹ ADHD risk alleles are associated with increased brain expression of ARTN and PIDD1 and with decreased brain expression of C2orf82. ▹ SNPs in C2orf82 correlate with changes in brain volumes. ▹ Our study highlights the ARTN, C2orf82 and PIDD1 genes as potential contributors to ADHD susceptibility. 74 Conclusions – Chapter 1 60
  • 75. ▹ We have performed a case-control association study to investigate the contribution to ADHD of common genetic variation in 1,761 autosomal miRNAs using pre-existing GWAS data from 20,000 cases and 35,000 controls. ▹ We have identified 19 significant associations of SNPs with ADHD that highlight 12 miRNA genes, all located within protein-coding genes. ▹ The associated variants are located in the putative regulatory regions of the miRNA genes or in the promoter region of the host protein-coding gene. ▹ The highlighted miRNAs are expressed in different brain tissues, specifically in cerebellum ▹ Three of the highlighted miRNAs - miR-3666, miR-7-1 and miR-1273h - have validated target mRNAs. ▹ Pathway analysis of ADHD- associated miRNAs revealed two biological pathways. One of the pathways involves miRNA-mediated regulation of serotonin receptor genes and it is likely to be involved in neurological functions and diseases. 75 Conclusions – Chapter 2 60
  • 76. ▹ We have performed the largest cocaine dependence GWAS meta- analysis in individuals of European ancestry, including 2,100 cases and 4,300 controls. ▹ Although the SNP-based analysis revealed no genome-wide significant associations with cocaine dependence, probably due to limited sample size, the gene-based analysis identified the HIST1H2BD gene, previously associated with schizophrenia. ▹ The estimated SNP-based heritability of cocaine dependence is approximately 30%. ▹ A significant genetic correlation has been observed between cocaine dependence and ADHD, schizophrenia, major depressive disorder and risk-taking behaviour, suggesting a shared genetic basis across pathologies and traits. ▹ Polygenic risk score (PRS) analysis shows that all the comorbid features analysed (ADHD, schizophrenia, major depressive disorder, aggressiveness, antisocial personality or risk-taking behaviour) can predict cocaine dependence 76 Conclusions – Chapter 3 60
  • 77. Genetics and epigenetics of attention- deficit/hyperactivity disorder and comorbid conditions Anu Shivalikanjli April 06, 2020 Profs. Bru Cormand and Stephen Faraone

Editor's Notes

  1. on cognitive symptoms of ADHD may involve differences in the structure and function of frontal-striatal-parietal-cerebellar pathways# https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720148/
  2. Smaller brain volumes hve been reported in brain volumes
  3.  https://www.biorxiv.org/content/10.1101/009449v1.full 3,418,270 SNPs from the GWAS meta-analysis to 18,069 protein-coding genes
  4. Association studies can address polygenicity and small effect sizes Whole exome /genome sequencing - rare
  5. ADHD is not only polygenic and hav env factors, Heritability calculated from twin studies- miss the epigenetic component, The proportion of susceptibility to adhd due to common snps
  6. Rule rather than exception
  7. https://www-sciencedirect-com.sire.ub.edu/science/article/pii/B9780128037508000397#f0010
  8. https://www-sciencedirect-com.sire.ub.edu/science/article/pii/B9780128037508000397#f0010
  9. Vulnerability factors that contribute to the development of cocaine dependence in ADHD patients.
  10. https://link.springer.com/article/10.1007%2Fs11920-014-0497-1
  11. https://onlinelibrary.wiley.com/doi/10.1111/pcn.12634
  12. https://onlinelibrary.wiley.com/doi/10.1111/pcn.12634
  13. Cpg within promoter regions --- located in other locations
  14. Mirna –regulationhttps://www.nature.com/articles/onc201059/figures/1
  15. Gene systems also available information
  16. Link SNPs/ genotypes with differential methylation of CpG
  17. Explore the performance of these 4K snps in largest adhd gwas
  18. ARTN-artemin Risk variants decrease the methylation – increases the expression
  19. ASM: Allele-specific methylation; N SNPs: Significant SNPs in the ADHD GWAS meta-analysis for the corresponding significance threshold; N ASM SNPs: Significant ASM SNPs in the GWAS meta-analysis; Underlined: Significant enrichment of ASM SNPs in the list of ADHD-associated SNPs; OR: Odds ratio.
  20. hat control the expression of the genes in datasets. Expanding beyond direct or single-hop relationships between the upstream regulator and the target molecules in the dataset, Causal Network Analysis uncovers networks of regulators that connect to the dataset targets. Focus on the networks that are of highest relevance by scoring the resulting causal networks against molecules, diseases, or functions of interest.
  21. hat control the expression of the genes in datasets. Expanding beyond direct or single-hop relationships between the upstream regulator and the target molecules in the dataset, Causal Network Analysis uncovers networks of regulators that connect to the dataset targets. Focus on the networks that are of highest relevance by scoring the resulting causal networks against molecules, diseases, or functions of interest.
  22. hat control the expression of the genes in datasets. Expanding beyond direct or single-hop relationships between the upstream regulator and the target molecules in the dataset, Causal Network Analysis uncovers networks of regulators that connect to the dataset targets. Focus on the networks that are of highest relevance by scoring the resulting causal networks against molecules, diseases, or functions of interest.
  23. hat control the expression of the genes in datasets. Expanding beyond direct or single-hop relationships between the upstream regulator and the target molecules in the dataset, Causal Network Analysis uncovers networks of regulators that connect to the dataset targets. Focus on the networks that are of highest relevance by scoring the resulting causal networks against molecules, diseases, or functions of interest.
  24. miR-4271  HTR1D miR-5193  HTR4 miR-4271  YWHAG SCZ + encoding a protein that mediates signal transduction by binding to phosphoserine-containing proteins. Mir-5193 Mir-7-1-3p Mir-3135a Mir-7a-5p mir6735 Mir6734 mir1273h
  25. 12 hits include protein-coding genes but also miRNAs --- researcher bias
  26. Linking CD to ADHD
  27. Cumulative p-value for genes
  28. SNPs in genomic risk loci are colour-coded as a function of their maximum r2 to the lead SNPs in the locus, as follows: red (r2 > 0.8), orange (r2 > 0.6), green (r2 > 0.4), blue (r2 > 0.2) and grey (r2 ≤ 0.2). The rs ID of the top SNPs in the risk locus is displayed in the most outer layer. Y-axis is ranged between 0 to the maximum -log10(p-value) of the SNPs. The second layer is the chromosome ring, with the genomic risk locus highlighted in blue. Here genes are mapped by chromatin interactions (orange) or eQTLs (green). When the gene is mapped by both, it is colored in red.
  29.  For LDSC, the estimated SNP heritability in liability scale was h2snp = 0.30 (SE = 0.06; P = 2.4e-07), and for GCTA-GREML h2snp = 0.27 (SE = 0.03, P < 0.01). Figure S3. Partitioning of heritability (h2) by functional annotations. Enrichment by 24 functional annotations defined by Finucane et al. (2015). Error bars represent 95% confidence intervals. P-values for annotation categories with nominally significant enrichment are shown and * indicates significance after Bonferroni correction (P < 2e-03). The horizontal black line indicates no enrichment. Significant enrichment in the heritability by SNPs located in intronic regions (enrichment = 2.17; SE = 0.45; P = 1.2e-03),  
  30. Results from LD Score (LDSC) regression analysis showing genetic correlation (rg) between cocaine dependence and several traits. Error bars indicate 95% confidence limits. The significance threshold was set to P < 7.1e-03. B) Best fit results from Polygenic Risk Score (PRS) analysis for each tested phenotype. Values displayed next to each bar represent the p-value for significance for the most predictive models. The significance threshold was set at P < 5.7e-04.
  31. Results from LD Score (LDSC) regression analysis showing genetic correlation (rg) between cocaine dependence and several traits. Error bars indicate 95% confidence limits. The significance threshold was set to P < 7.1e-03. B) Best fit results from Polygenic Risk Score (PRS) analysis for each tested phenotype. Values displayed next to each bar represent the p-value for significance for the most predictive models. The significance threshold was set at P < 5.7e-04.